EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

Lucia Carril-Ajuria, Pernelle Lavaud, Cecile Dalban, Sylvie Negrier, Gwénaëlle Gravis, Robert J Motzer, Christine Chevreau, Nizar M Tannir, Stéphane Oudard, David F McDermott, Brigitte Laguerre, Hans J Hammers und 10 weitere

European Journal of Cancer · 2024-06 · 204 · 114048

DOI: 10.1016/j.ejca.2024.114048 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Cancer, 2024-06. Verfasst von Lucia Carril-Ajuria und 21 weiteren Autor:innen. Beteiligte Einrichtung: Gustave Roussy, Villejuif, France. Electronic address: carrilajuria.lucia@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Bristol-Myers Squibb, Unicancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsLung NeoplasmsHumansMaleFemaleMiddle AgedAgedPrognosisProspective StudiesBiomarkers, TumorSunitinibImmune Checkpoint InhibitorsNivolumabProgression-Free SurvivalAdult

Stichwörter der Autor:innen

AntiangiogenicsBiomarkersLIPIPrognosisRenal cell carcinomaimmune checkpoint inhibitors

Substanzen

Biomarkers, TumorSunitinibImmune Checkpoint InhibitorsNivolumab

Autor:innen und Institutionen

  • Gustave Roussy, Villejuif, France. Electronic address: carrilajuria.lucia@gmail.com.
  • Gustave Roussy, Villejuif, France.
  • Department of Biostatistics, Centre Leon Bernard, Lyon, France.
  • Université de Lyon, Centre Leon Bernard, Lyon, France.
  • Institut Paoli-Calmettes, Aix-Marseille, France.
  • Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Förderung

  • NCI NIH HHS
  • Bristol-Myers Squibb
  • Unicancer

Zitieren

APA

Carril-Ajuria, L., Lavaud, P., Dalban, C., Negrier, S., Gravis, G., Motzer, R. J., Chevreau, C., Tannir, N. M., Oudard, S., McDermott, D. F., Laguerre, B., Hammers, H. J., Barthelemy, P., Plimack, E. R., Borchiellini, D., Gross-Goupil, M., Jiang, R., Lee, C. W., de Silva, H., …, & Albigès, L. (2024). Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma. European Journal of Cancer, 204, 114048. https://doi.org/10.1016/j.ejca.2024.114048

Vancouver

Carril-Ajuria L, Lavaud P, Dalban C, Negrier S, Gravis G, Motzer RJ, et al. Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma. European Journal of Cancer. 2024;204:114048. doi:10.1016/j.ejca.2024.114048

BibTeX
@article{CarrilAjuria2024,
  author = {Carril-Ajuria, Lucia and Lavaud, Pernelle and Dalban, Cecile and Negrier, Sylvie and Gravis, Gwénaëlle and Motzer, Robert J and Chevreau, Christine and Tannir, Nizar M and Oudard, Stéphane and McDermott, David F and Laguerre, Brigitte and Hammers, Hans J and Barthelemy, Philippe and Plimack, Elizabeth R and Borchiellini, Delphine and Gross-Goupil, Marine and Jiang, Ruiyun and Lee, Chung-Wei and de Silva, Heshani and Rini, Brian I and Escudier, Bernard and Albigès, Laurence},
  title = {Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {204},
  pages = {114048},
  doi = {10.1016/j.ejca.2024.114048}
}
Kostenlos starten →